📰 Breakthrough Device News
Page 11 - Breakthrough Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Device. Real-time updates on events, politics, business and more.
June 30, 2023
Renalytix announced on Friday that the US Food and Drug Administration (FDA) had granted De Novo marketing authorisation for its ‘KidneyIntelX.dkd’ prognostic test.
June 29, 2023
In November 2021, the Centers for Medicare & Medicaid Services (CMS) rescinded a short-lived program to expedite national Medicare coverage for innovative devices amid safety concerns...
June 29, 2023
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development...
June 28, 2023
SEOUL, Korea, June 28, 2023 (GLOBE NEWSWIRE) -- Kalos Medical Inc. (“Kalos Medical”), a developer of innovative medical devices treating hypertension and other chronic illnesses, announced on June 23rd that
June 28, 2023
On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) released a Notice with Comment Period (Notice) proposing a new Transitional Coverage for Emerging Technologies...
June 28, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
June 21, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
June 16, 2023
Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility Study Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing a
June 16, 2023
SAN FRANCISCO, June 16, 2023--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced the details of its poster presentation at the European Association for the Study of the Liver (EASL) Congress 2023, being held from June 21-24 in Vienna, Austria. EASL is a leading professional society and
June 16, 2023
Per Protocol Participants saw an 85% Reduction in the Loss of Vertebral Bone Density in One Year...